Stifel Nicolaus Starts Aratana Therapeutics (PETX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
William Blair Starts Aratana Therapeutics (PETX) at Outperform
July 23, 2013 7:27 AM EDTWilliam Blair initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with an Outperform.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
July 23, 2013 7:16 AM EDTLazard Capital initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $28.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
JMP Securities Starts Aratana Therapeutics (PETX) at Market Outperform
July 22, 2013 9:01 AM EDTJMP Securities initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Market Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
Craig-Hallum Starts Aratana Therapeutics (PETX) at Buy
July 22, 2013 9:00 AM EDTCraig-Hallum initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
